Showing results (41-50 of 59) with videos related to
Sort By:
Pageof 6
Annals of the New York Academy of Sciences|July 9, 2003
COX-2 and neurodegeneration in Parkinson's diseaseP Teismann, M Vila, D-K Choi, et al.Experimental Neurology|April 1, 1994
Differences in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/bl and CD-1 miceU Muthane, K A Ramsay, H Jiang, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 11, 2000
Delaying caspase activation by Bcl-2: A clue to disease retardation in a transgenic mouse model of amyotrophic lateral sclerosisS Vukosavic, L Stefanis, V Jackson-Lewis, et al.Proceedings of the National Academy of Sciences of the United States of America|February 28, 2001
Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's diseaseM Vila, V Jackson-Lewis, S Vukosavic, et al.Proceedings of the National Academy of Sciences of the United States of America|September 2, 1998
Selectively enhanced contextual fear conditioning in mice lacking the transcriptional regulator CCAAT/enhancer binding protein deltaE Sterneck, R Paylor, V Jackson-Lewis, et al.Brain Research|June 7, 1991
Sham transplantation protects against 6-hydroxydopamine-induced dopaminergic toxicity in rats: behavioral and morphological evidenceS Przedborski, M Levivier, V Kostic, et al.Brain Research|December 11, 1989
Regional effects of 6-hydroxydopamine (6-OHDA) on free radical scavengers in rat brainA S Perumal, W K Tordzro, M Katz, et al.Neurology|December 12, 2001
Metabolic correlates of levodopa response in Parkinson's diseaseA Feigin, M Fukuda, V Dhawan, et al.Current Opinion in Neurology|July 27, 2001
The role of glial cells in Parkinson's diseaseM Vila, V Jackson-Lewis, C Guégan, et al.The Journal of Comparative Neurology|July 25, 2000
Developmental cell death in dopaminergic neurons of the substantia nigra of miceV Jackson-Lewis, M Vila, R Djaldetti, et al.Pageof 6